GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » CK Life Sciences International Holdings Inc (FRA:LSI) » Definitions » Price-to-Owner-Earnings

CK Life Sciences International Holdings (FRA:LSI) Price-to-Owner-Earnings : (As of May. 16, 2024)


View and export this data going back to . Start your Free Trial

What is CK Life Sciences International Holdings Price-to-Owner-Earnings?

As of today (2024-05-16), CK Life Sciences International Holdings's share price is €0.0475. CK Life Sciences International Holdings does not have enough data to calculate Owner Earnings per Share (TTM), so as pPrice-to-Owner-Earnings.


The historical rank and industry rank for CK Life Sciences International Holdings's Price-to-Owner-Earnings or its related term are showing as below:

FRA:LSI' s Price-to-Owner-Earnings Range Over the Past 10 Years
Min: 22.5   Med: 45   Max: 410
Current: 65

During the past 13 years, the highest Price-to-Owner-Earnings of CK Life Sciences International Holdings was 410.00. The lowest was 22.50. And the median was 45.00.


FRA:LSI's Price-to-Owner-Earnings is ranked worse than
70.24% of 168 companies
in the Biotechnology industry
Industry Median: 34.045 vs FRA:LSI: 65.00

As of today (2024-05-16), CK Life Sciences International Holdings's share price is €0.0475. CK Life Sciences International Holdings's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was €0.00. Therefore, CK Life Sciences International Holdings's PE Ratio for today is N/A.

As of today (2024-05-16), CK Life Sciences International Holdings's share price is €0.0475. CK Life Sciences International Holdings's EPS without NRI for the trailing twelve months (TTM) ended in was €-0.00. Therefore, CK Life Sciences International Holdings's PE Ratio without NRI for today is At Loss.

During the past 13 years, CK Life Sciences International Holdings's highest PE Ratio without NRI was 227.50. The lowest was 12.59. And the median was 35.00.


CK Life Sciences International Holdings Price-to-Owner-Earnings Historical Data

The historical data trend for CK Life Sciences International Holdings's Price-to-Owner-Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CK Life Sciences International Holdings Price-to-Owner-Earnings Chart

CK Life Sciences International Holdings Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Price-to-Owner-Earnings
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

CK Life Sciences International Holdings Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Price-to-Owner-Earnings Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of CK Life Sciences International Holdings's Price-to-Owner-Earnings

For the Biotechnology subindustry, CK Life Sciences International Holdings's Price-to-Owner-Earnings, along with its competitors' market caps and Price-to-Owner-Earnings data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


CK Life Sciences International Holdings's Price-to-Owner-Earnings Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, CK Life Sciences International Holdings's Price-to-Owner-Earnings distribution charts can be found below:

* The bar in red indicates where CK Life Sciences International Holdings's Price-to-Owner-Earnings falls into.



CK Life Sciences International Holdings Price-to-Owner-Earnings Calculation

In 1986 Berkshire Hathaway Shareholder Letter, Warren Buffett defined owner earnings as follows:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume. (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

CK Life Sciences International Holdings's Price-to-Owner-Earnings for today is calculated as

Price-to-Owner-Earnings=Share Price/Owner Earnings per Share (TTM)
=0.0475/0.00
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


CK Life Sciences International Holdings  (FRA:LSI) Price-to-Owner-Earnings Explanation

For how to get Owner Earnings per Share (TTM), please click.


CK Life Sciences International Holdings Price-to-Owner-Earnings Related Terms

Thank you for viewing the detailed overview of CK Life Sciences International Holdings's Price-to-Owner-Earnings provided by GuruFocus.com. Please click on the following links to see related term pages.


CK Life Sciences International Holdings (FRA:LSI) Business Description

Traded in Other Exchanges
Address
2 Dai Fu Street, Tai Po Industrial Estate, Tai Po, Hong Kong, HKG
CK Life Sciences International Holdings Inc is a biotechnology company engaged in the research & development, commercialization, and sale of health and agricultural-related products. Products developed by CK Life Sciences are categorized into the areas of human health and environmental sustainability. The company operates three core businesses, including agriculture, nutraceutical, and pharmaceutical. Its overall product portfolio involves a presence that spans North America and the Asia Pacific. The company uses mergers and acquisitions when it identifies attractive market opportunities.